Ken Griffin’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,209
| Closed | -$1.38K | – | 5791 |
|
|
2025
Q1 | $1.38K | Sell |
2,209
-34,886
| -94% | -$21.7K | ﹤0.01% | 5783 |
|
|
2024
Q4 | $61.9K | Buy |
+37,095
| New | +$61.9K | ﹤0.01% | 5395 |
|
|
2024
Q3 | – | Sell |
-68,511
| Closed | -$413K | – | 5747 |
|
|
2024
Q2 | $413K | Sell |
68,511
-1,166,704
| -94% | -$7.04M | ﹤0.01% | 3982 |
|
|
2024
Q1 | $13.8M | Buy |
1,235,215
+2,108
| +0.2% | +$23.5K | ﹤0.01% | 1094 |
|
|
2023
Q4 | $18.4M | Buy |
1,233,107
+807,890
| +190% | +$12M | ﹤0.01% | 900 |
|
|
2023
Q3 | $2.04M | Buy |
425,217
+222,934
| +110% | +$1.07M | ﹤0.01% | 2363 |
|
|
2023
Q2 | $1.52M | Sell |
202,283
-40,599
| -17% | -$305K | ﹤0.01% | 2644 |
|
|
2023
Q1 | $1.1M | Buy |
242,882
+101,533
| +72% | +$459K | ﹤0.01% | 3084 |
|
|
2022
Q4 | $1.59M | Sell |
141,349
-97,037
| -41% | -$1.09M | ﹤0.01% | 2780 |
|
|
2022
Q3 | $2.28M | Buy |
238,386
+160,131
| +205% | +$1.53M | ﹤0.01% | 2607 |
|
|
2022
Q2 | $633K | Sell |
78,255
-55,775
| -42% | -$451K | ﹤0.01% | 3906 |
|
|
2022
Q1 | $2.27M | Buy |
134,030
+45,456
| +51% | +$768K | ﹤0.01% | 2875 |
|
|
2021
Q4 | $1.9M | Sell |
88,574
-5,145
| -5% | -$111K | ﹤0.01% | 3121 |
|
|
2021
Q3 | $6.92M | Buy |
93,719
+71,183
| +316% | +$5.26M | ﹤0.01% | 1761 |
|
|
2021
Q2 | $1.23M | Sell |
22,536
-36,677
| -62% | -$2.01M | ﹤0.01% | 3742 |
|
|
2021
Q1 | $4.37M | Sell |
59,213
-224,043
| -79% | -$16.5M | ﹤0.01% | 2257 |
|
|
2020
Q4 | $24.4M | Buy |
+283,256
| New | +$24.4M | 0.01% | 752 |
|